Cargando…

Molecular mechanisms of azole resistance in Candida bloodstream isolates

BACKGROUND: Antifungal resistance rates are increasing. We investigated the mechanisms of azole resistance of Candida spp. bloodstream isolates obtained from a surveillance study conducted between 2012 and 2015. METHODS: Twenty-six azole non-susceptible Candida spp. clinical isolates were investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teo, Jocelyn Qi-Min, Lee, Shannon Jing-Yi, Tan, Ai-Ling, Lim, Robyn Su-May, Cai, Yiying, Lim, Tze-Peng, Kwa, Andrea Lay-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337757/ https://www.ncbi.nlm.nih.gov/pubmed/30654757 http://dx.doi.org/10.1186/s12879-019-3672-5

Ejemplares similares

Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot
por: Teo, Jocelyn Qi Min, et al.
Publicado: (2016)

Mechanisms of Azole Resistance and Trailing in Candida tropicalis Bloodstream Isolates
por: Chen, Pao-Yu, et al.
Publicado: (2021)

Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
por: Lim, Tze-Peng, et al.
Publicado: (2018)

In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates
por: Lim, Tze-Peng, et al.
Publicado: (2023)

Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution
por: Liew, Yi Xin, et al.
Publicado: (2015)

Using an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 Hours
por: Cai, Yiying, et al.
Publicado: (2015)

Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea
por: Lee, Jin-Sol, et al.
Publicado: (2007)

Azole-resistant Candida blankii as a newly recognized cause of bloodstream infection
por: Al-Haqqan, A., et al.
Publicado: (2018)

2107. Azole Therapeutic Drug Monitoring (TDM) in a Multiracial Cohort with Varied Pharmacogenetics
por: Yvonne Zhou, Peijun, et al.
Publicado: (2019)

Correction to: Candidemia in a major regional tertiary referral hospital – epidemiology, practice patterns and outcomes
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2018)

Candidemia in a major regional tertiary referral hospital – epidemiology, practice patterns and outcomes
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2017)

Risk Factors, Molecular Epidemiology and Outcomes of Ertapenem-Resistant, Carbapenem-Susceptible Enterobacteriaceae: A Case-Case-Control Study
por: Teo, Jocelyn, et al.
Publicado: (2012)

Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital
por: Martini, Cecilia, et al.
Publicado: (2020)

Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study
por: Cai, Yiying, et al.
Publicado: (2020)

Virulence Traits and Azole Resistance in Korean Candida auris Isolates
por: Byun, Seung A., et al.
Publicado: (2023)

From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)
por: Cai, Yiying, et al.
Publicado: (2016)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

Correction: Chen et al. Mechanisms of Azole Resistance and Trailing in Candida tropicalis Bloodstream Isolates. J. Fungi 2021, 7, 612
por: Chen, Pao-Yu, et al.
Publicado: (2021)

Azole potentiation in Candida species
por: Stenkiewicz-Witeska, Jan S., et al.
Publicado: (2023)

In vitro Bactericidal Activities of Combination Antibiotic Therapies Against Carbapenem-Resistant Klebsiella pneumoniae With Different Carbapenemases and Sequence Types
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis
por: Paul, Saikat, et al.
Publicado: (2022)

Elimination of Extracellular Adenosine Triphosphate for the Rapid Prediction of Quantitative Plate Counts in 24 h Time-Kill Studies against Carbapenem-Resistant Gram-Negative Bacteria
por: Cai, Yiying, et al.
Publicado: (2020)

Paradigm Shift: Candida parapsilosis sensu stricto as the Most Prevalent Candida Species Isolated from Bloodstream Infections with Increasing Azole-Non-Susceptibility Rates: Trends from 2015–2022 Survey
por: Franconi, Iacopo, et al.
Publicado: (2023)

Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
por: Tan, Jingwen, et al.
Publicado: (2021)

In Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs
por: Zomorodian, Kamiar, et al.
Publicado: (2016)

Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China
por: Yao, Dongting, et al.
Publicado: (2019)

S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis
por: Ghosh, Anup, et al.
Publicado: (2022)

Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study
por: Hoo, Grace S. R., et al.
Publicado: (2022)

Potential role of broad-spectrum azoles as therapy for Malasezzia bloodstream infection
por: Shah, Sunish, et al.
Publicado: (2023)

Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Genomic evolution towards azole resistance in Candida glabrata clinical isolates unveils the importance of CgHxt4/6/7 in azole accumulation
por: Galocha, Mónica, et al.
Publicado: (2022)

Upregulation of the ERG11 gene in Candida krusei by azoles
por: Tavakoli, M., et al.
Publicado: (2010)

Azole Compounds as Inhibitors of Candida albicans: QSAR Modelling
por: Gheidari, Davood, et al.
Publicado: (2021)

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
por: Shinde, Ravikumar Bapurao, et al.
Publicado: (2013)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

A Preliminary in vitro and in vivo Evaluation of the Effect and Action Mechanism of 17-AAG Combined With Azoles Against Azole-Resistant Candida spp.
por: Liu, Luyao, et al.
Publicado: (2022)

Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species
por: Silva, Danielly Beraldo dos Santos, et al.
Publicado: (2016)

High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran
por: Zarrinfar, Hossein, et al.
Publicado: (2021)

P079 Virulence factors and azole-resistant mechanism of Candida tropicalis isolated from candidemia
por: Sarvestani, Elahe Sasani, et al.
Publicado: (2022)

Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
por: Alabi, Philip E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_44roc1o5le4veicrfadf5n1q5o